PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 261 of 640

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Clinical course study of postoperative recovery of neurosensory disturbance after inferior alveolar nerve transection during sagittal split osteotomy

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Diagnostic accuracy and smoking-driven modulation of salivary MMP-8, MMP-9, and HIF-1α in stage III grade B/C periodontitis: a cross-sectional study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Preserflo microshunt outcomes in pigmentary glaucoma: a propensity score–matched comparison with primary open-angle glaucoma

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Does ocular dominance change after epiretinal membrane development?

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Investigating PXR (NR1I2) genetic polymorphisms as possible determinants of the magnitude of the clindamycin–rifampicin pharmacokinetic interaction

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Sustainability in Hard Conditions – Based Algorithm and Strategy of Companies in Oncology Pharmaceutical Manufacturing – Based Optimization for Power Loss Reduction

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical progress note: Hepatitis B

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Separation and recovery of Ni <sup>2+</sup> by foam separation using soapberry extract

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Intraoral Er:YAG laser‐assisted de‐epithelialization of autogenous gingival grafts for soft tissue management

CrossrefOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sen. Warren demands answers from RFK Jr. over 'calamitous' response to cyclosporiasis outbreak

6abc PhiladelphiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Stockholder Alert: Robbins LLP Informs Investors of the Aardvark Therapeutics, Inc. (UWM) Class Action

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Disc Medicine COO Jonathan Yu sells $66,444 in shares

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?

Yahoo! Finance CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MeiraGTx (MGTX) Stock Jumps After Profit Shock Raises Durability Questions

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Editorial | Hong Kong is stepping up its contribution to global healthcare

South China Morning PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dino Rossi Sells 25,000 Shares of Krystal Biotech (NASDAQ:KRYS) Stock

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ctt pharmaceutical holdings CEO Ryan Khouri buys $111 in stock By Investing.com

Investing.com South AfricaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Releases Q2 2026 Financial Results

AlphaStreetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ctt pharmaceutical holdings CEO Ryan Khouri buys $111 in stock By Investing.com

Investing.com South AfricaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Redx Pharma

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ctt pharmaceutical holdings CEO Ryan Khouri buys $111 in stock

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism

STATOriginal source
🌍Researchuab.eduTier 2 · Direct publisher

UAB startup NuVasc is advancing precision medicine for brain arteriovenous malformations

University of Alabama at BirminghamOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc. SEC Filing (Aug 14, 2026)

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New pharmaceutical campus near Lake Houston, SHSU college name change: 7 trending stories from across the North Houston area

Community ImpactOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Garabedian on Biotech's Post-Deal 'Shoes That Drop': Seven Vykat XR Deaths and Amgen's Tavneos Pull

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech (NASDAQ: MBRX) seeks reverse split and plan changes at 2026 meeting

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More

fool.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Soticlestat Revived: Perceptive Advisors Bets FDA Rejected Trial Design, Not Drug Itself

Tech TimesOriginal source
🌍Industryallogene.comTier 1 · Company source

SCHEDULE 13G/A: SCHEDULE 13G/A – Description

Allogene TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

American Vietnamese Biotech, Inc. Revenue Breakdown – HNX:AMV

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BullFrog AI Holdings (BFRG) posts Q2 2026 loss, flags going concern and Nasdaq risks

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vistagen Therapeutics (VTGN) flags going concern risk amid Q1 loss and Nasdaq pressure

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LeonaBio (LONA) loss widens as cash burn rises and going concern risk emerges

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Achieve Life Sciences (ACHV) launches $150M at-the-market stock program

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Processa Pharmaceuticals (NASDAQ: PCSA) lands $183M funding and Vidya BTK acquisition

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

'After eateries and street food stalls, we will inspect PG kitchens': Food Safety Commissioner Srinivas K

Deccan HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why This Top 3% Biotech Just Catapulted To A Record High

Investor's Business DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update

globenewswire.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup

NeurologyLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Raphael Pharmaceutical (RAPH) cuts losses but warns of going‑concern risk amid $1K cash

Stock TitanOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ProKidney: Do-Or-Die Phase 3 Meets A Dwindling Balance Sheet (Rating Downgrade) (PROK)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vets ‘at the heart’ of wildlife pharmaceutical overuse, says leading clinician

vettimes.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbCellera's nonhormonal menopause drug shows early success

Drug Discovery NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate |

KIPOSTOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CPHI Milan Puts Sustainability to Work, Part 2

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA gives recall of 19 million eggs its highest risk classification

Houston ChronicleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech Gets $7 Million Investment From Perceptive Advisors

MoomooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Definium Therapeutics' Voyage Trial Success Reshapes Valuation Debate for Anxiety Drug

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves new Alzheimer’s PET imaging agent from Lantheus

Radiology BusinessOriginal source
🇺🇸CROveristat.comTier 2 · Direct publisher

Monthly FDA Guidance and Regulatory News Review - July 2026

VeristatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GOLDENWELL BIOTECH, INC. Q2 2026: Revenue $0 Net loss $(36,876), EPS $(0.00037) — 10-Q Summary

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune: FDA Suspends Licence Of Iconic Burger King Outlet In Camp After Food Safety Violations

lokmattimes.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Clears First CELMoD Agent, Dana-Farber Aids Progress

Mirage NewsOriginal source